News
Discover the latest news stories, blog posts and publications from Cobra's expert team
Posts by Tag
- August 2020 (6)
- November 2017 (4)
- April 2020 (4)
- May 2013 (3)
- October 2013 (3)
- April 2017 (3)
- July 2017 (3)
- January 2018 (3)
- November 2019 (3)
- March 2020 (3)
- October 2020 (3)
- June 2011 (2)
- October 2011 (2)
- February 2012 (2)
- June 2012 (2)
- October 2012 (2)
- March 2013 (2)
- February 2014 (2)
- March 2014 (2)
- June 2014 (2)
- February 2015 (2)
- September 2015 (2)
- June 2016 (2)
- November 2016 (2)
- January 2017 (2)
- December 2017 (2)
- February 2018 (2)
- March 2018 (2)
- September 2018 (2)
- October 2019 (2)
- January 2011 (1)
- February 2011 (1)
- July 2011 (1)
- September 2012 (1)
- November 2012 (1)
- January 2013 (1)
- June 2013 (1)
- August 2013 (1)
- December 2013 (1)
- January 2014 (1)
- April 2014 (1)
- May 2014 (1)
- September 2014 (1)
- December 2014 (1)
- March 2015 (1)
- April 2015 (1)
- May 2015 (1)
- July 2015 (1)
- August 2015 (1)
- November 2015 (1)
- February 2016 (1)
- March 2016 (1)
- May 2016 (1)
- July 2016 (1)
- October 2016 (1)
- March 2017 (1)
- May 2017 (1)
- September 2017 (1)
- October 2017 (1)
- April 2018 (1)
- May 2018 (1)
- June 2018 (1)
- October 2018 (1)
- November 2018 (1)
- January 2019 (1)
- June 2019 (1)
- September 2019 (1)
- January 2020 (1)
- June 2020 (1)
- September 2020 (1)
or
Posts by Tag
- General (22)
- Gene Therapy (21)
- DNA (18)
- blog (16)
- Viral Vectors (14)
- vaccine (13)
- COVID-19 (10)
- Coronavirus (9)
- Collaboration (8)
- Manufacturing (8)
- business (7)
- expansion (7)
- gene (7)
- therapy (7)
- AAV (6)
- Awards (6)
- award (6)
- international trade (6)
- CombiGene (5)
- cell therapy (5)
- immunotherapy (5)
- investment (5)
- plasmid dna (5)
- Cobra Biologics (4)
- Innovate UK (4)
- News (4)
- Proteins (4)
- STEM (4)
- University (4)
- development (4)
- #21Cmed (3)
- Advanced Therapy Medicinal Product (3)
- Alligator (3)
- CG01 (3)
- CMO (3)
- CPI (3)
- Cognate BioServices (3)
- Featured (3)
- Innovate (3)
- adeno-associated virus (3)
- cell (3)
- clinical trials (3)
- epilepsy (3)
- export (3)
- grant (3)
- jobs (3)
- maxXpress (3)
- oxford (3)
- process (3)
- viral (3)
- A-level choices (2)
- Advanced Therapies Manufacturing Taskforce (2)
- AstraZeneca (2)
- Careers in Science (2)
- Centre for Process Innovation (2)
- Expertise (2)
- Finalists (2)
- GCSE options (2)
- GE Healthcare (2)
- GMP (2)
- Immune-oncology (2)
- Immuno-Oncology (2)
- Industrial Strategy (2)
- Manchester (2)
- Pharma (2)
- Quality (2)
- Queen's Award (2)
- Staffordshire (2)
- Trade (2)
- UK medicine (2)
- acquisition (2)
- antibody (2)
- articles (2)
- bacteria (2)
- biologics (2)
- biopharmaceuticals (2)
- branding (2)
- cell line development (2)
- clinical (2)
- competition (2)
- education (2)
- expression (2)
- interview (2)
- medicine (2)
- microbioreactor (2)
- peer reviewed (2)
- plasmid (2)
- regenerative (2)
- science (2)
- single-use (2)
- vector (2)
- vectors (2)
- viral vector (2)
- vlog (2)
- ADC-1013 (1)
- ADCs (1)
- ATMP (1)
- BioSpace (1)
- Bionow (1)
- Bioscience (1)
- CAR-T (1)
- CDMO (1)
- CSO (1)
- Cancer (1)
- Capabilities (1)
- Capsules (1)
- Cell and Gene Therapy Catapult (1)
- Chambers (1)
- Cobra (1)
- Commerce (1)
- Compatibility (1)
- Director (1)
- Engineered (1)
- Future (1)
- Highlights (1)
- Innovation (1)
- Internal (1)
- Leukoencephalopathy (1)
- MHRA (1)
- Manufacturer (1)
- Multifocal (1)
- NEUWAY (1)
- Pall Corporation (1)
- ProFuse (1)
- Progressive (1)
- Puridify (1)
- Reliability (1)
- Sartorius (1)
- Sheffield (1)
- Staffs (1)
- Stedim (1)
- SwedenBIO (1)
- Symbiosis (1)
- Technologies (1)
- Tokyo (1)
- Tony Hitchcock (1)
- Touchlight (1)
- UCOE (1)
- UKTI (1)
- Viruses (1)
- Webinar (1)
- YEOTY (1)
- adenovirus (1)
- advanced (1)
- alevel choices (1)
- antibodies (1)
- baculovirus (1)
- bioreactor (1)
- careers (1)
- cmo leadership award (1)
- commercial supply (1)
- compliance (1)
- costs (1)
- covid19 (1)
- degree choices (1)
- department (1)
- disease (1)
- disposables (1)
- event (1)
- goals (1)
- growth (1)
- jenner institute (1)
- leadership (1)
- life (1)
- line (1)
- microbial (1)
- mobile (1)
- neurodegenerative (1)
- new website (1)
- of (1)
- operations (1)
- orphan (1)
- partnership (1)
- partnerships (1)
- processes (1)
- promising technologist (1)
- protein (1)
- rare (1)
- rare disease day (1)
- regulatory (1)
- relationship (1)
- responsive (1)
- risk (1)
- scancell (1)
- scientist (1)
- service (1)
- social media (1)
- solid (1)
- studies (1)
- study (1)
- supply (1)
- survey (1)
- technology (1)
- therapeutics (1)
- timelines (1)
- toxicity (1)
- trial (1)
- trials (1)
- tumours (1)
- visitor experience (1)
- web design (1)
- website (1)
Posts about
competition
Cobra Biologics and Symbiosis Awarded £1.9m ($2.5m USD) Innovate UK Grant
- Gene Therapy, Advanced Therapy Medicinal Product, Innovate UK, viral vector, Manufacturing, expansion, investment, jobs, grant, competition, Industrial Strategy, Immune-oncology, UK medicine
Funding will be used to develop world-leading capabilities in drug substance and drug product viral vector production for gene and immunotherapy
Cobra Biologics, an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services, a contract manufacturing organisation (CMO) specialising in sterile Fill Finish, today announced that they have been awarded a 16-month collaborative grant of £1.9m from Innovate UK.
Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UK
- DNA, Gene Therapy, Advanced Therapy Medicinal Product, Innovate UK, viral vector, Manufacturing, expansion, investment, jobs, grant, competition, Industrial Strategy, Immune-oncology, UK medicine
Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK
Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK Award made as part of UK’s Innovation Agency’s Industrial Strategy boost for UK medicines with £70m of funding to help develop new treatments Cobra Biologics, an international CDMO of biologics and pharmaceuticals, announced that it has been awarded £2.6 million ($3.4 million) capital infrastructure investment by